At the current stage, in order to investigate the pathological relevance of hypoxia-responsive MT2A in breast cancer, we analyzed the human breast cancer single-cell RNA sequencing (scRNA-seq) dataset (Wu et al., 2021b) to examine the correlation between MT2A expression patterns and tumor hypoxic status. This evidence concerns the gene MT2A and breast carcinoma.